GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates AS (OCSE:VIRO) » Definitions » Other Operating Expense

ViroGates AS (OCSE:VIRO) Other Operating Expense : kr0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates AS Other Operating Expense?

ViroGates AS's Other Operating Expense for the three months ended in Mar. 2025 was kr0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

ViroGates AS's quarterly Other Operating Expense declined from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil) but then stayed the same from Dec. 2024 (kr0.00 Mil) to Mar. 2025 (kr0.00 Mil).

ViroGates AS's annual Other Operating Expense declined from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) and declined from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr-0.00 Mil).


ViroGates AS Other Operating Expense Historical Data

The historical data trend for ViroGates AS's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates AS Other Operating Expense Chart

ViroGates AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only - - - - -

ViroGates AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ViroGates AS Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViroGates AS Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ViroGates AS's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


ViroGates AS Business Description

Traded in Other Exchanges
Address
Banevaenget 13, Birkerod, DNK, DK-3460
ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates AS Headlines

No Headlines